Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | OAF | Human | (+)-schisandrin B | multiple interactions | ISO | Oaf (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of OAF mRNA] | CTD | PMID:31150632 | OAF | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Oaf (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of OAF mRNA | CTD | PMID:36331819 | OAF | Human | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | increases expression | EXP | | 6480464 | o and p'-DDT results in increased expression of OAF mRNA | CTD | PMID:18204070 | OAF | Human | 17beta-estradiol | increases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of OAF mRNA | CTD | PMID:32145629 | OAF | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of OAF mRNA | CTD | PMID:20106945 | OAF | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Oaf (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of OAF mRNA | CTD | PMID:26377647 | OAF | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of OAF mRNA | CTD | PMID:21215274 and PMID:34747641 | OAF | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of OAF mRNA | CTD | PMID:22298810 | OAF | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Oaf (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of OAF mRNA | CTD | PMID:19770486 | OAF | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Oaf (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of OAF mRNA | CTD | PMID:19933214 | OAF | Human | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of OAF mRNA | CTD | PMID:37199045 | OAF | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Oaf (Mus musculus) | 6480464 | [bisphenol S co-treated with Tretinoin] results in decreased expression of OAF mRNA | CTD | PMID:30951980 | OAF | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | Oaf (Mus musculus) | 6480464 | bisphenol S results in increased expression of OAF mRNA | CTD | PMID:30951980 | OAF | Human | 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole | affects expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Omeprazole affects the expression of OAF mRNA | CTD | PMID:19483382 | OAF | Human | 6-propyl-2-thiouracil | affects expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Propylthiouracil affects the expression of OAF mRNA | CTD | PMID:19483382 | OAF | Human | acetamide | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | acetamide results in decreased expression of OAF mRNA | CTD | PMID:31881176 | OAF | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of OAF mRNA | CTD | PMID:32763439 | OAF | Human | aflatoxin B1 | decreases expression | ISO | Oaf (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of OAF mRNA | CTD | PMID:19770486 | OAF | Human | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of OAF mRNA | CTD | PMID:27153756 | OAF | Human | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of OAF protein | CTD | PMID:20106945 | OAF | Human | Aflatoxin B2 alpha | decreases methylation | EXP | | 6480464 | aflatoxin B2 results in decreased methylation of OAF intron | CTD | PMID:30157460 | OAF | Human | all-trans-retinoic acid | multiple interactions | ISO | Oaf (Mus musculus) | 6480464 | [bisphenol S co-treated with Tretinoin] results in decreased expression of OAF mRNA | CTD | PMID:30951980 | OAF | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of OAF mRNA | CTD | PMID:33167477 | OAF | Human | alpha-Zearalanol | multiple interactions | ISO | Oaf (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of OAF mRNA | CTD | PMID:35163327 | OAF | Human | amiodarone | affects expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Amiodarone affects the expression of OAF mRNA | CTD | PMID:18355885 and PMID:19483382 | OAF | Human | amitriptyline | affects expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Amitriptyline affects the expression of OAF mRNA | CTD | PMID:18355885 | OAF | Human | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of OAF mRNA | CTD | PMID:24449571 | OAF | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of OAF mRNA | CTD | PMID:33212167 | OAF | Human | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of OAF mRNA | CTD | PMID:22378314 | OAF | Human | benzbromarone | affects expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Benzbromarone affects the expression of OAF mRNA | CTD | PMID:19483382 | OAF | Human | benzo[a]pyrene | multiple interactions | ISO | Oaf (Mus musculus) | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to OAF promoter] | CTD | PMID:19654925 | OAF | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of OAF promoter | CTD | PMID:27901495 | OAF | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of OAF mRNA | CTD | PMID:22316170 | OAF | Human | benzo[a]pyrene | decreases expression | ISO | Oaf (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of OAF mRNA | CTD | PMID:19770486 | OAF | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of OAF mRNA | CTD | PMID:20106945 and PMID:32234424 | OAF | Human | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of OAF mRNA | CTD | PMID:31163220 | OAF | Human | bisphenol A | affects expression | ISO | Oaf (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of OAF mRNA | CTD | PMID:25181051 more ... | OAF | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of OAF gene | CTD | PMID:31601247 | OAF | Human | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of OAF gene | CTD | PMID:31601247 | OAF | Human | bisphenol A | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of OAF mRNA | CTD | PMID:34947998 | OAF | Human | bisphenol A | increases expression | ISO | Oaf (Mus musculus) | 6480464 | bisphenol A results in increased expression of OAF mRNA | CTD | PMID:30951980 more ... | OAF | Human | bisphenol A | increases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of OAF mRNA | CTD | PMID:30816183 and PMID:32528016 | OAF | Human | bisphenol F | increases expression | ISO | Oaf (Mus musculus) | 6480464 | bisphenol F results in increased expression of OAF mRNA | CTD | PMID:30951980 | OAF | Human | calcium silicate | increases expression | ISO | Oaf (Mus musculus) | 6480464 | calcium silicate results in increased expression of OAF mRNA | CTD | PMID:29279043 | OAF | Human | carbon nanotube | decreases expression | ISO | Oaf (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | OAF | Human | carbon nanotube | increases expression | ISO | Oaf (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | OAF | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to OAF gene] | CTD | PMID:28238834 | OAF | Human | clofibrate | affects expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Clofibrate affects the expression of OAF mRNA | CTD | PMID:19483382 | OAF | Human | clomipramine | affects expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Clomipramine affects the expression of OAF mRNA | CTD | PMID:18355885 | OAF | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of OAF mRNA | CTD | PMID:19549813 | OAF | Human | coumarin | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | coumarin results in decreased expression of OAF mRNA | CTD | PMID:18480146 | OAF | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of OAF mRNA | CTD | PMID:20106945 | OAF | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of OAF mRNA | CTD | PMID:27989131 | OAF | Human | dibutyl phthalate | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in decreased expression of OAF mRNA | CTD | PMID:21266533 | OAF | Human | diethyl maleate | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | diethyl maleate results in decreased expression of OAF mRNA | CTD | PMID:21161181 | OAF | Human | dioxygen | decreases expression | EXP | | 6480464 | Oxygen deficiency results in decreased expression of OAF mRNA | CTD | PMID:26516004 | OAF | Human | diuron | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Diuron results in decreased expression of OAF mRNA | CTD | PMID:25152437 | OAF | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OAF mRNA | CTD | PMID:27188386 | OAF | Human | ethanol | increases expression | ISO | Oaf (Mus musculus) | 6480464 | Ethanol results in increased expression of OAF mRNA | CTD | PMID:30319688 | OAF | Human | fenthion | decreases expression | ISO | Oaf (Mus musculus) | 6480464 | Fenthion results in decreased expression of OAF mRNA | CTD | PMID:34813904 | OAF | Human | fipronil | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | fipronil results in decreased expression of OAF mRNA | CTD | PMID:23962444 | OAF | Human | flutamide | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Flutamide results in decreased expression of OAF mRNA | CTD | PMID:24136188 and PMID:24793618 | OAF | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of OAF gene | CTD | PMID:31601247 | OAF | Human | furan | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | furan results in decreased expression of OAF mRNA | CTD | PMID:25539665 and PMID:26194646 | OAF | Human | glafenine | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Glafenine results in decreased expression of OAF mRNA | CTD | PMID:24136188 | OAF | Human | glutathione | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Glutathione deficiency results in decreased expression of OAF mRNA | CTD | PMID:20621112 | OAF | Human | imipramine | affects expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Imipramine affects the expression of OAF mRNA | CTD | PMID:18355885 | OAF | Human | ketoconazole | affects expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Ketoconazole affects the expression of OAF mRNA | CTD | PMID:18355885 | OAF | Human | L-ethionine | affects expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Ethionine affects the expression of OAF mRNA | CTD | PMID:19483382 | OAF | Human | leflunomide | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | leflunomide results in decreased expression of OAF mRNA | CTD | PMID:24136188 | OAF | Human | N-methyl-N-nitrosourea | increases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Methylnitrosourea results in increased expression of OAF mRNA | CTD | PMID:17412507 | OAF | Human | N-nitrosodiethylamine | multiple interactions | ISO | Oaf (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of OAF mRNA | CTD | PMID:28943392 | OAF | Human | nefazodone | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | nefazodone results in decreased expression of OAF mRNA | CTD | PMID:24136188 | OAF | Human | nimesulide | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | nimesulide results in decreased expression of OAF mRNA | CTD | PMID:24136188 | OAF | Human | omeprazole | affects expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Omeprazole affects the expression of OAF mRNA | CTD | PMID:19483382 | OAF | Human | p-toluidine | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | 4-toluidine results in decreased expression of OAF mRNA | CTD | PMID:27638505 | OAF | Human | paracetamol | affects expression | ISO | Oaf (Mus musculus) | 6480464 | Acetaminophen affects the expression of OAF mRNA | CTD | PMID:17562736 | OAF | Human | paracetamol | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of OAF mRNA | CTD | PMID:32479839 and PMID:33387578 | OAF | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of OAF mRNA | CTD | PMID:21420995 and PMID:29067470 | OAF | Human | parathion | decreases expression | ISO | Oaf (Mus musculus) | 6480464 | Parathion results in decreased expression of OAF mRNA | CTD | PMID:34813904 | OAF | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Oaf (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of OAF mRNA | CTD | PMID:36331819 | OAF | Human | perfluorooctanoic acid | multiple interactions | ISO | Oaf (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of OAF mRNA | CTD | PMID:35163327 | OAF | Human | phenformin | increases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Phenformin results in increased expression of OAF mRNA | CTD | PMID:31324951 | OAF | Human | piperonyl butoxide | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Piperonyl Butoxide results in decreased expression of OAF mRNA | CTD | PMID:22484513 | OAF | Human | pirinixic acid | decreases expression | ISO | Oaf (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of OAF mRNA | CTD | PMID:18445702 | OAF | Human | pirinixic acid | affects expression | ISO | Oaf (Rattus norvegicus) | 6480464 | pirinixic acid affects the expression of OAF mRNA | CTD | PMID:19483382 | OAF | Human | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of OAF mRNA | CTD | PMID:21632981 | OAF | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OAF mRNA | CTD | PMID:27188386 | OAF | Human | silicon dioxide | decreases methylation | EXP | | 6480464 | Silicon Dioxide results in decreased methylation of OAF promoter | CTD | PMID:34973136 | OAF | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of OAF mRNA | CTD | PMID:29301061 | OAF | Human | Soman | increases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Soman results in increased expression of OAF mRNA | CTD | PMID:19281266 | OAF | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of OAF mRNA | CTD | PMID:31533062 | OAF | Human | tetrachloromethane | decreases expression | ISO | Oaf (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of OAF mRNA | CTD | PMID:17484886 more ... | OAF | Human | tetrachloromethane | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of OAF mRNA | CTD | PMID:31150632 | OAF | Human | tetrachloromethane | multiple interactions | ISO | Oaf (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of OAF mRNA] | CTD | PMID:31150632 | OAF | Human | thapsigargin | decreases expression | ISO | Oaf (Mus musculus) | 6480464 | Thapsigargin results in decreased expression of OAF protein | CTD | PMID:24648495 | OAF | Human | thioacetamide | affects expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Thioacetamide affects the expression of OAF mRNA | CTD | PMID:19483382 | OAF | Human | thioacetamide | multiple interactions | ISO | Oaf (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of OAF mRNA | CTD | PMID:28943392 | OAF | Human | thioacetamide | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of OAF mRNA | CTD | PMID:23411599 and PMID:34492290 | OAF | Human | titanium dioxide | decreases expression | ISO | Oaf (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of OAF mRNA | CTD | PMID:29264374 | OAF | Human | triphenyl phosphate | increases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | triphenyl phosphate results in increased expression of OAF mRNA | CTD | PMID:30589522 | OAF | Human | troglitazone | increases expression | ISO | Oaf (Mus musculus) | 6480464 | troglitazone results in increased expression of OAF mRNA | CTD | PMID:28973697 | OAF | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of OAF mRNA | CTD | PMID:28818685 | OAF | Human | ursodeoxycholic acid | affects expression | EXP | | 6480464 | Ursodeoxycholic Acid affects the expression of OAF mRNA | CTD | PMID:18422935 | OAF | Human | valdecoxib | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | valdecoxib results in decreased expression of OAF mRNA | CTD | PMID:24136188 | OAF | Human | valproic acid | affects expression | ISO | Oaf (Mus musculus) | 6480464 | Valproic Acid affects the expression of OAF mRNA | CTD | PMID:17963808 | OAF | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OAF mRNA | CTD | PMID:27188386 | OAF | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of OAF mRNA | CTD | PMID:26272509 | OAF | Human | vinclozolin | decreases expression | ISO | Oaf (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of OAF mRNA | CTD | PMID:23034163 | |